Phase II study of docetaxel and capecitabine as 1st line therapy for patients with locally advanced or metastatic gastric cancer
Phase of Trial: Phase II
Latest Information Update: 17 Apr 2007
At a glance
- Drugs Capecitabine; Docetaxel
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 01 Nov 2005 New trial record.